Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for biopharmaceuticals and therapeutic proteins
3.2.1.2 Advancements in protein engineering
3.2.1.3 Growing prevalence of chronic and infectious diseases
3.2.2 Industry pitfalls & challenges
3.2.2.1 High production costs
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Products & Services, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Products
5.2.1 Cytokines & growth factors
5.2.1.1 Interferons (IFNs)
5.2.1.2 Interleukins (ILs)
5.2.1.3 Other cytokines & growth factors
5.2.2 Antibodies
5.2.3 Immune checkpoint proteins
5.2.4 Virus antigens
5.2.5 Enzymes
5.2.5.1 Kinases
5.2.5.2 Metabolic enzymes
5.2.5.3 Other enzymes
5.2.6 Recombinant regulatory proteins
5.2.7 Hormones
5.2.8 Other products
5.3 Production services
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Drug discovery & development
6.2.1 Biologics
6.2.2 Vaccines
6.2.3 Cell & gene therapies
6.3 Research
6.4 Diagnostics
6.5 Other applications
Chapter 7 Market Estimates and Forecast, By Host-cell, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Mammalian systems
7.3 Insect cells
7.4 Yeast & fungi
7.5 Bacterial cells
7.6 Other host-cells
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical & biotechnology companies
8.3 Academic & research institutes
8.4 Contract research organizations (CRO's)
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abcam Limited
10.2 Abnova Corporation
10.3 Bio-Rad Laboratories, Inc.
10.4 Enzo Life Sciences, Inc.
10.5 GenScript Biotech Corporation
10.6 Merck KGaA
10.7 Proteintech Group, Inc.
10.8 RayBiotech, Inc.
10.9 R&D Systems, Inc.
10.10 Sino Biological, Inc.
10.11 STEMCELL Technologies Inc.
10.12 Thermo Fisher Scientific Inc.
